blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1299562

EP1299562 - GENE EXPRESSION IN BIOLOGICAL CONDITIONS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  07.01.2011
Database last updated on 25.09.2024
Most recent event   Tooltip07.01.2011Application deemed to be withdrawnpublished on 09.02.2011  [2011/06]
Applicant(s)For all designated states
AROS APPLIED BIOTECHNOLOGY APS
Østjysk Innovation, Gustav Wieds Vej 10
8000 Arhus C / DK
[N/P]
Former [2003/15]For all designated states
AROS APPLIED BIOTECHNOLOGY APS
c/o stjysk Innovation, Gustav Wieds Vej 10
8000 Rhus C / DK
Inventor(s)01 / ORNTOFT, Torben, F.
Helgesvej 19
DK-8230 Aabyhoj / DK
02 / THYKJAER, Thomas
Tranebaervej 26
DK-8220 Brabrand / DK
03 / DEMTRÖDER, Karin
Solbakken 13
DK-8410 Ronde / DK
 [2003/15]
Representative(s)Høiberg P/S
Adelgade 12
1304 Copenhagen K / DK
[N/P]
Former [2003/22]HOEIBERG A/S
European Patent & Trademark Attorneys Store Kongensgade 59A
1264 Copenhagen K / DK
Former [2003/15]Hoeiberg, Susanne, et al
Hoeiberg A/S St. Kongensgade 59 A
DK-1264 Copenhagen K / DK
Application number, filing date01949274.302.07.2001
[2003/15]
WO2001DK00463
Priority number, dateDK2000000102030.06.2000         Original published format: DK 200001020
[2003/15]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO0202804
Date:10.01.2002
Language:EN
[2002/02]
Type: A1 Application with search report 
No.:EP1299562
Date:09.04.2003
Language:EN
The application published by WIPO in one of the EPO official languages on 10.01.2002 takes the place of the publication of the European patent application.
[2003/15]
Search report(s)International search report - published on:EP10.01.2002
ClassificationIPC:C12Q1/68, A61K48/00, A61K39/395, A61K38/00
[2003/15]
CPC:
C07K14/47 (EP,US); A61K2039/53 (EP,US); A61K48/00 (EP,US)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2003/15]
Extension statesAL30.01.2003
LT30.01.2003
LV30.01.2003
MK30.01.2003
RO30.01.2003
SI30.01.2003
TitleGerman:GENE EXPRESSION IN BIOLOGISCHEN GEWEBEN[2003/15]
English:GENE EXPRESSION IN BIOLOGICAL CONDITIONS[2003/15]
French:EXPRESSION GENIQUE DANS DES ETATS BIOLOGIQUES[2003/15]
Entry into regional phase30.01.2003National basic fee paid 
30.01.2003Designation fee(s) paid 
30.01.2003Examination fee paid 
Examination procedure23.01.2002Request for preliminary examination filed
International Preliminary Examining Authority: EP
27.01.2003Amendment by applicant (claims and/or description)
30.01.2003Examination requested  [2003/15]
12.02.2010Despatch of a communication from the examining division (Time limit: M06)
24.08.2010Application deemed to be withdrawn, date of legal effect  [2011/06]
24.09.2010Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2011/06]
Fees paidRenewal fee
30.06.2003Renewal fee patent year 03
02.08.2004Renewal fee patent year 04
01.08.2005Renewal fee patent year 05
31.07.2006Renewal fee patent year 06
31.07.2007Renewal fee patent year 07
25.07.2008Renewal fee patent year 08
28.07.2009Renewal fee patent year 09
26.07.2010Renewal fee patent year 10
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[PX]WO0052204  (ORNTOFT TORBEN F [DK]) [PX] 1-10,19-42,46,50-61,70-86,88,89,91-93,95-113 * abstract *;
 [X]WO9951772  (INCYTE PHARMA INC [US]) [X] 1-10,19-42,46,50-61,70-86,88,89,91-93,95-113 * page 10, line 15 - line 20 *;
 [X]WO9710365  (AFFYMAX TECH NV [NL], et al) [X] 1-10,19-42,46,50-61,70-86,88,89,91-93,95-113 * page 1, line 16 - page 2, line 2 *;
 [X]WO9853319  (UNIV JOHNS HOPKINS [US], et al) [X] 1-10,19-42,46,50-61,70-86,88,89,91-93,95-113 * abstract *;
 [X]WO9521944  (SMITHKLINE BEECHAM CORP [US], et al) [X] 1-10,19-42,46,50-61,70-86,88,89,91-93,95-113 * abstract *;
 [X]WO9630389  (MILLENNIUM PHARM INC [US]) [X] 1-10,19-42,46,50-61,70-86,88,89,91-93,95-113 * abstract *;
 [X]  - MARC O GRIMM ET AL, "Expression and progression pattern of transitional cell carcinoma of the bladder", THE JOURNAL OF UROLOGY, (200005), vol. 163, no. 4, page 127, XP002902076 [X] 1-10,19-42,46,50-61,70-86,88,89,91-93,95-113 * abstract *
 [A]  - TORBEN F ORNTOFT ET AL, "Molecular alterations in bladder cancer", UROL RES, (1998), vol. 26, pages 223 - 233, XP002902077 [A] 1-10,19-42,46,50-61,70-86,88,89,91-93,95-113 * page 229, column 2, line 24 - page 230, column 1, line 9 *

DOI:   http://dx.doi.org/10.1007/s002400050050
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.